Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-β

被引:14
|
作者
Puissant-Lubrano, Benedicte [1 ,2 ]
Viala, Frederique
Winterton, Peter [2 ]
Abbal, Michel [1 ,2 ]
Clanet, Michel
Blancher, Antoine [1 ,2 ]
机构
[1] CHU Toulouse, Hop Rangueil, Immunol Lab, F-31059 Toulouse 9, France
[2] Univ Toulouse 3, Fac Med Toulouse Rangueil, Immunogenet Mol Lab, F-31062 Toulouse 4, France
关键词
multiple sclerosis; thymic function; regulatory T cells; IFN-beta treatment; T cell subsets; CD45RC;
D O I
10.1016/j.jneuroim.2007.10.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We explored the parameters of central and peripheral tolerance in patients with stable relapsing-remitting multiple sclerosis, treated or not with IFN-beta TREC-positive T cells were lower in patients compared with controls, mainly in CD4+ subset, compatible with a thymus dysfunction or an expansion of peripheral lymphocytes. Compared to controls, the frequency of activated CD4+CD25+ T cells was higher in patients without modification of the CD4+CD25(high) T cell proportion. The IFN-beta-treatment did not modify the TREC-positive cell frequency nor the naive/memory T cell subset percentage but was associated with lower blood lymphocyte count and a lower frequency of CD4+CD45RC(high) subset. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 50 条
  • [31] Fatigue in Treated and Untreated Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
    Yaldizli, Oe
    Katsarava, Z.
    Vago, S.
    Limmroth, V.
    Putzki, N.
    AKTUELLE NEUROLOGIE, 2008, 35 (09) : 425 - 429
  • [32] Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis
    Bilinska, Malgorzata
    Frydecka, Irena
    Podemski, Ryszard
    Teodorowska, Renata
    Gruszka, Ewa
    MEDICAL SCIENCE MONITOR, 2001, 7 (02): : 251 - 255
  • [33] IFN-β1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis
    Waubant, E
    Gee, L
    Miller, K
    Stabler, G
    Goodkin, D
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (03): : 181 - 185
  • [34] LYMPHOCYTE SUBSETS IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - A LONGITUDINAL-STUDY OF B-LYMPHOCYTES AND T-LYMPHOCYTES
    SCOTT, TF
    MCKOLANIS, J
    ROTHFUS, W
    COTTINGTON, E
    NEUROLOGICAL RESEARCH, 1994, 16 (05) : 385 - 388
  • [35] IL-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone
    Losy, J.
    Szczucinski, A.
    MULTIPLE SCLEROSIS, 2007, 13 : S37 - S37
  • [36] Immunomodulatory effects of IFN-β1a treatment alone or associated with pentoxifylline in patients with relapsing-remitting multiple sclerosis (RRMS)
    Di Pede, P
    Visintini, D
    Telera, A
    Cucurachi, L
    Campanini, C
    Immovilli, P
    Vescovini, R
    Sansoni, P
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (08): : 485 - 489
  • [37] A comparison of the biologic activity of two recombinant IFN-β preparations used in the treatment of relapsing-remitting multiple sclerosis
    Antonetti, F
    Finocchiaro, O
    Mascia, M
    Terlizzese, MG
    Jaber, A
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (12): : 1181 - 1184
  • [38] Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients
    Berthelot, Laureline
    Miqueu, Patrick
    Pettre, Segolene
    Guillet, Marina
    Moynard, Julien
    Wiertlewski, Sandrine
    Lefrere, Fabienne
    Brouard, Sophie
    Soulillou, Jean-Paul
    Laplaud, David-Axel
    CLINICAL IMMUNOLOGY, 2010, 135 (01) : 33 - 42
  • [39] Determinants of Gd-enhanced MRI response to IFN-β-I a treatment in relapsing-remitting multiple sclerosis
    Koudriavtseva, T
    Pozzilli, C
    Fiorelli, M
    Gasperini, C
    Bagnato, F
    Galgani, S
    Frontoni, M
    Ciccarelli, O
    Bastianello, S
    MULTIPLE SCLEROSIS, 1998, 4 (05): : 403 - 407
  • [40] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47